Loading company…
Unicellab develops and manufactures pharmaceutical ingredients using crystal form research and co-crystal technology.
Based in South Korea, Unicellab researches and produces active pharmaceutical ingredients, developing crystal forms, polymorphs, salts and amorphous substances using co-crystal technology. Founded in 2018, the company raised an undisclosed amount of venture funding from Yozma Group Korea in February 2019. Ahn Ji-hoon was CEO as of 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in